Category: Stroke Prevention

Statin Use Post-Radiation Tied to Significant Stroke Reduction

Long-known as an effective treatment method for a variety of cancers, radiation therapy (RT) is performed on more than half of all cancer patients. While it effectively eradicates cancer cells and decreases tumor size, it can also cause adverse effects that include scarring or thickening of the arteries, putting patients at an increased risk for cardiovascular and cerebrovascular events. As a risk factor, radiation-induced atherosclerosis correlates to a higher likelihood of cardiovascular disease, the leading cause of morbidity and mortality in cancer survivors. 

New research published in the Journal of the American Heart Association suggests the potential of the cholesterol-lowering drug family of statins to significantly reduce cardiovascular and cerebrovascular risks in patients affected by certain cancers. To date, there have been no studies exploring the effects of statin use on vascular complications in cancer patients post thorax, head, and neck radiotherapy although, the anti-inflammatory properties of statins have been shown to reduce the risk of vascular disease through the reduction of plaque formation. 

Read more

The Link Between Stress & Strokes

Clinical data has established a connection between stress and cardiovascular disease, identifying chronic stress as a risk factor for acute cardiovascular syndromes, which could potentially be included in risk assessments of cardiovascular disease in daily clinical practice: particularly given the increasing number of individuals with chronic stress.

An important study utilizing brain scans previously demonstrated the link between stress and heart attacks or strokes, confirming that people who have increased activity in their amygdala—often termed the ‘fear center’ of the brain—are at higher risks for cardiovascular disease. While stress can activate the amygdala, leading to extra immune cell production by the bone marrow, the arteries may become inflamed, leading to cardiovascular disease.

The study tracked the health of 293 adults for two to five years, during which 22 patients experienced a cardiovascular disease event, such as a stroke, heart attack, or coronary heart failure. Researchers found that those people with more active amygdalas were more likely to have a critically serious heart event over the next few years; additionally, they had more inflammation in their arteries, which ultimately leads to heart disease, and bone marrow activity that may be linked with blood clots. 

The link was strong, even when taking into account additional factors like smoking, lipids, diabetes, and hypertension. The subjects with higher activity in the amygdala developed heart attacks and strokes sooner than those who showed lower activity. The sub-study from Mount Sinai demonstrated that the subjects’ psychosocial stress level – assessed using a stress questionnaire – went hand-in-hand with amygdalar activity: measured with imaging.

The leader of the team, Dr. Ahmed Tawakol of Massachusetts General Hospital and Harvard Medical School, expressed that chronic stress could eventually be treated as an important risk factor for cardiovascular disease. The study also provides new insights into how to reduce stress-related cardiovascular diseases, which involve the heart or blood vessels, and are the leading cause of death and women around the world—according to the World Health Organization.

In the United States, more than one in three adults has at least one type of cardiovascular disease, and heart disease has been confirmed as the leading cause of death in the country. While smaller stress reduction studies have been promising, large trials are still needed to confirm that treating stress actually reduces heart attacks. In the meantime, it is reasonable to recommend stress reduction techniques to patients with higher stress levels, and an increased risk of heart disease. Controlling stress should be part of the dialogue between patient and physician, in addition to diet and exercise: when discussing strategies to combat cardiovascular disease.